ClinicalTrials.gg
Active, not recruitingNCT02600910NHSSIUpdated Oct 29, 2026

Natural History of Shoulder Pathology in Manual Wheelchair Users

An observational study in Paraplegia, Spinal Cord Injuries and Shoulder Pain, sponsored by The University of Texas Medical Branch, Galveston. Active, not recruiting at 2 sites in United States. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-29.

Sponsored by The University of Texas Medical Branch, Galveston · Observational

How we know

Updated Oct 29, 2026Study documents postedSponsor changed+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
75
Ages
18 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 64 studies in Paraplegia with a site in United States — 17 open to participants now, 18 under way, 2 of them phase 3. Paraplegia · United States.

Planned enrollment
4th of 10
75 · median 58
Started
2015
with 4 others
Observational
10 of 64
2 open now
Primary completion
2027-06
later than 7 of 17 live
Registered
26th of 64
by date

Among the 64 studies in Paraplegia with a site in United States, this one is the 4th largest by planned enrollment of the 10 observational ones that give a count, is one of 5 that started in 2015, is one of 10 observational ones, reaches primary completion later than 7 of the 17 other live ones, and was the 26th registered.

Paraplegia

152 studies on the registry are indexed under Paraplegia; 37 are open to participants now.

Browse Paraplegia studies →

Open to participants now

17 of the 64 studies in Paraplegia with a site in United States are open now. Recruiting first, the newest first:

12 more — sign in →

All 17 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 32 Paraplegia studies recruiting now, 15 (47%) set no upper age limit and 14 (44%) stop at 75 or younger; 6 take children under 18; 4 take healthy volunteers.

This study: 18 Years to 70 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 64 studies in Paraplegia with a site in United States, or all of them as a file.
02

Study summary

Over 300,000 people in the United States have spinal cord injuries and many use manual wheelchairs for mobility. Most manual wheelchair users will develop shoulder injuries and pain that greatly affect quality of life and level of independence. Understanding when shoulder disease starts in manual wheelchair users and which daily activities contribute to the disease will provide necessary evidence for effective primary prevention methods to inhibit the development of further disability. Our central hypothesis is that the development of shoulder disease in manual wheelchair users will be strongly associated with the cumulative exposure to elevated shoulder postures combined with high upper body loading.

Read the detailed description

Of the 1.7 million wheelchair users in the United States (US), 90 percent, or 1.5 million persons use manual wheelchairs (MWCs). People with traumatic and non-traumatic spinal cord injuries (SCI) make up approximately 20% of the MWC users, and 12,000 new traumatic SCIs occur every year. While MWCs are immediately available and enable independence, 63% of MWC users will have one or multiple rotator cuff tears after decades of MWC use as compared to 15% of age-matched able-bodied adults. A crucial gap in knowledge exists in understanding how the shoulder of MWC users functions from an almost permanent seated position as an agent for mobility, weight bearing, and hand grasping; and how this altered function translates to longitudinal shoulder health decline.

The objective of this application is to define the longitudinal components of the early phase (before chronic symptom onset) of shoulder health decline specific to new MWC users by characterizing the exposure to altered shoulder function and the associated MRI signs of early onset of shoulder pathology. The investigators propose to: (Aim 1) quantify shoulder joint motion and loading in the real world over 3 years in 50 new MWC users and a matched able-bodied cohort; (Aim 2) define early, preclinical changes on shoulder MRI specific to the MWC users, over 3 years, in comparison to the matched cohort; and (Aim 3) identify specific exposure measures as risk factors for early changes on MRI in the MWC users. Three central and novel aspects of this proposal will pave the way for targeting primary prevention: (1) characterizing the altered shoulder function in new MWC users in the real world with hardware and instrumentation suitable for multiple, day long collections, (2) defining the early, preclinical pattern of disease in users compared to a matched able-bodied cohort, and (3)investigating the combined effect of shoulder motion and loading and its relationship to the incidence of shoulder pathology.

Successful completion of this project will define how the shoulder responds to MWC use (Aim 1), identify the MWC-specific pattern of shoulder disease on MRI (Aim 2), and determine how altered shoulder function has contributed to shoulder health decline (Aim 3). This work provides the foundation for understanding the relative impact of shoulder elevation and loading in shoulder health decline. Additionally, this work provides the first building block in defining the complete natural history of shoulder disease in MWC users. The investigators expect the overall impact to be a powerful influence on environmental and assistive technology redesign, post-SCI rehabilitation practices, insurance reimbursement for shoulder health-preserving equipment, and understanding shoulder pathology in the general population.

03

Conditions studied

  • Paraplegia
  • Spinal Cord Injuries
  • Shoulder Pain
  • Tendinopathy

Keywords

  • Manual Wheelchair
  • Shoulder injury
  • Shoulder function
  • rotator cuff
  • Tendinopathy
  • Spinal cord injury
  • Shoulder pain
  • Shoulder impingement
04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

50 new manual wheelchair users with traumatic or non-traumatic spinal cord injuries (SCI) will be recruited \& consented during the first 2 years of this project. Subjects will be recruited at sites that treat \& rehabilitate people with acute SCI. SE MN \& neighboring states will be the 1st regions of recruitment. The inclusion and exclusion criteria were chosen to include a sample of the population of people with new SCIs who will use MWCs as their primary mode of mobility inside and outside the home. For 25 SCI participants, an age, sex, and activity level able-bodied matched participant will be recruited from the SE MN area.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Group1 (Manual Wheelchair User Cohort):

  • Participants with traumatic or non-traumatic spinal cord injury who have begun using a MWC within 12 months of enrollment
  • 18 - 70 years of age
  • Use of a manual wheelchair as the primary mode of mobility
  • Functional upper extremity range of motion
  • Willingness to participate in study
  • Ability to return to receive shoulder MRI 1-3 times/year , and once per year receive physical exam, and strength assessments.

Group 2 (Matched Able-bodied Cohort):

  • 18-70 years of age
  • Able to walk independently with no reliance on an orthotic, prosthetic, or gait aid
  • Functional upper extremity range of motion
  • Willingness to participate in study
  • Ability to receive shoulder MRI 1-3 times/year, and once per year receive physical exam, and strength assessments.

Exclusion criteria

Exclusion Criteria:

Group1 (Manual Wheelchair User Cohort):

  • Previous diagnosis of bilateral shoulder tendon tears prior to spinal cord injury or suspected tendon tears with physical exam

Group 2 (Matched Able-bodied Cohort):

  • Any documented musculoskeletal or neurological disorders that would be expected to impact shoulder health or change ability to walk independently
  • Previous diagnosis of shoulder tears prior to enrollment or suspected tendon tears with physical exam
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
75 participants (estimated)
Patient registry
No

Groups and cohorts

  • Manual Wheelchair User Cohort

    Physical Exam. Screening exam performed by a licensed physical therapist to confirm inclusion/exclusion criteria. Assessment of Shoulder Function in Everyday Life. Shoulder motion \& hand loading data will be collected over a few days, twice per yr for 3-5 yrs in home \& community environment. Magnetic Resonance Imaging (MRI) of Shoulders. Imaging will use standard clinical protocol once per yr for 3-5 yrs. Shoulder Strength Testing. Once per yr for 3-5 yrs. Additional Variables. Updated demographic info will be collected yearly including but not limited to weight, chair type, health status, and job type.

  • Matched Able-bodied Cohort

    Physical Exam. Screening exam performed by a licensed physical therapist to confirm inclusion/exclusion criteria. Assessment of Shoulder Function in Everyday Life. Shoulder motion \& hand loading data will be collected over a few days, twice per yr for 3-5 yrs in home \& community environment. Magnetic Resonance Imaging (MRI) of Shoulders. Imaging will use standard clinical protocol once per yr for 3-5 yrs. Shoulder Strength Testing. Once per yr for 3-5 yrs. Additional Variables. Updated demographic info will be collected yearly including but not limited to weight, health status, and job type.

06

What researchers measure

Primary outcomes

  1. Participant completion of MRI and Field measurements after 3 to 5 years follow-up.

    Investigators will use the standardized MRI Assessment of the shoulder guide to assess shoulder pathology and compare baseline shoulder condition on MRI to yearly follow-up. For the purposes of grading, pathology aside from rotator cuff tears will be assessed on an ordinal scale from 0-3 with 0 indicating no abnormality, 1 mild, 2 moderate, and 3 severe. Field measurements will be used to determine changes in upper extremity motion and loading from baseline across 3-5 years of follow-up.

    Time frame: 3-5 years

Secondary outcomes

  1. Development of the Conceptual Model of Preclinical Natural History of Shoulder Health Decline.

    Investigators will model the preclinical phase of shoulder health decline based on the Natural History of Disease. The exposure variables are defined by the upper extremity motion and loading, and the biological onset of the disease and pattern of disease development will be defined with the MRI findings of pathology type, location, and severity. Using regression techniques, an exposure-response relationship will be defined.

    Time frame: 3-5 years

07

Study locations

2 sites
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Undecided — This will be decided further into the study.

09

Timeline

2 registry updates since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimatedDate before it movedWhere the date was before it moved

The record gives a start of Nov 2015, a primary completion of Jun 2027 and a completion of Jun 2027. It does not say whether these dates are actual or estimated.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 15, 2026: primary completion Aug 2026 → Jun 2027 and completion Aug 2026 → Jun 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Nov 6, 2015
First posted
Nov 9, 2015
Start
Nov 2015
Primary completionEst.
Jun 2027was Aug 2026
CompletionEst.
Jun 2027was Aug 2026
Last update
Oct 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Aug 2026→Jun 2027
Oct 15, 2026
Study completion
Aug 2026→Jun 2027
Oct 15, 2026
Sponsor
Collaborators added: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Oct 29, 2026
Show all 2 updates
  1. Oct 29, 2026
    Sponsor Collaborators added: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
  2. Oct 15, 2026
    Primary completion Aug 2026→Jun 2027
    Study completion Aug 2026→Jun 2027
    + 3 other changes: identifiers, verification date and oversight details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT02600910
Responsible party
Sponsor
First posted
Nov 9, 2015
Start date
Nov 2015
Primary completion
Jun 2027 (estimated)
Completion
Jun 2027 (estimated)
Last update
Oct 29, 2026

Study contacts

Melissa Morrow
principal investigator · University of Texas Medical Branch, Galveston

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion